Cognitive FX treatment outcomes

This is the short version of what studies of Cognitive FX treatment found. Every study, with its source and its limits, is on Cognitive FX research and results.

Last reviewed .

Measured outcome, independent study

77%In an independent study by Amsterdam UMC and UMC Groningen, 77% of the 52 patients measured six months after treatment had a clinically meaningful reduction in symptoms. Observational, not randomized. Individual results vary.

Source: van Doorn et al., Tijdschrift voor Neuropsychologie 19(2), 110-138, 2024.

Each dot is one of the 52 patients measured six months after treatment. The 40 filled dots had a clinically meaningful reduction in symptoms.

Patient-reported, UMCG survey

94%In a survey by University Medical Center Groningen (UMCG), 94% of 76 Dutch patients with acquired brain injury reported that their symptoms improved after treatment at Cognitive FX.

Source: Groenewold & Verheij, 2019 (unpublished UMCG pilot study), reported in van Doorn et al., Tijdschrift voor Neuropsychologie, 2024, p. 112.

Key facts

Who ran the study
Amsterdam UMC and UMC Groningen ran the study. Cognitive FX did not write or fund it.
Study design
Observational, with measurements before treatment and one week, one month and six months after. Not randomized, no control group.
Time since injury
The independent study was designed for Cognitive FX patients treated at least twelve months after their injury (two of the 64 started at about eleven months).
Cognitive FX's own data
In a Cognitive FX study of 375 patients, the average symptom score fell from 33.5 to 14.9 during the treatment week (Epps et al., 2019).

See all research and results, including every study, how results are measured, the limits of the research, and what treatment costs.